YUEXIU PROPERTY (00123) has been granted a HK$300 million term loan facility.
YUEXIU PROPERTY (00123) announced that on September 22, 2026, the Company (as borrower) entered into a facility agreement (the Facility Agreement) with a bank (the Lender), pursuant to which the Lender, subject to the terms and conditions of the Facility Agreement, will provide a HK$300 million term loan facility, with a loan period of 364 days from the date of first drawdown.
YUEXIU PROPERTY (00123) announced that on September 22, 2026, the Company (as borrower) entered into a facility agreement (the Facility Agreement) with a bank (the Lender), pursuant to which the Lender will provide, subject to the terms and conditions of the Facility Agreement, a HK$300 million term loan facility with a loan period of 364 days from the date of first drawdown.
Related Articles
HANSOH PHARMA (03692): Injection of Reconnective Votutamab (HS-20093) for the treatment of osteosarcoma included in the priority review and approval process of the National Medical Products Administration
.png)
CIMC ENRIC (03899) repurchased 200,000 shares for HK$1.456 million on September 22.
FIH (02038) spent HKD 948,300 to repurchase 60,000 shares on September 22.
HANSOH PHARMA (03692): Injection of Reconnective Votutamab (HS-20093) for the treatment of osteosarcoma included in the priority review and approval process of the National Medical Products Administration
CIMC ENRIC (03899) repurchased 200,000 shares for HK$1.456 million on September 22.
FIH (02038) spent HKD 948,300 to repurchase 60,000 shares on September 22.
